3.94
price up icon5.07%   0.19
after-market Dopo l'orario di chiusura: 3.94
loading

Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie

pulisher
Nov 02, 2025

Should you hold or exit Vistagen Therapeutics Inc. nowWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will breakout in Vistagen Therapeutics Inc. lead to full recoveryWeekly Stock Summary & Consistent Profit Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Vistagen Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Strategies to average down on Vistagen Therapeutics Inc.July 2025 Volume & Free Community Supported Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Technical signs of recovery in Vistagen Therapeutics Inc.CPI Data & Community Consensus Stock Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What dividend safety score for Vistagen Therapeutics Inc. stock2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Vistagen Therapeutics Inc. stock gain from strong economy2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Vistagen Therapeutics Inc. stock reversal real or fakeRecession Risk & Community Consensus Trade Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 04:45:37 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Vistagen Therapeutics Inc. stock benefit from green energy trendsJuly 2025 Technicals & Safe Capital Growth Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Combining machine learning predictions for Vistagen Therapeutics Inc.CEO Change & Reliable Price Action Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to recover losses in Vistagen Therapeutics Inc. stockJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Vistagen Therapeutics Inc. a candidate for recovery playJuly 2025 Summary & Verified Momentum Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Vistagen Therapeutics Inc. stock remain a Wall Street favoriteForecast Cut & Precise Buy Zone Identification - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Vistagen Therapeutics Inc. stock a safe haven assetTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How to escape a deep drawdown in Vistagen Therapeutics Inc.Day Trade & Low Risk Investment Opportunities - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

VistaGen Therapeutics Appoints Paul R. Edick to Board - The Globe and Mail

Oct 30, 2025
pulisher
Oct 30, 2025

Vistagen’s Promising Phase 2 Trial for Anxiety Treatment: A Market Game Changer? - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Can Vistagen Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Catalysts & Real-Time Market Trend Scan - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 03:05:01 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

VistaGen Therapeutics (VTGN) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 30, 2025
pulisher
Oct 29, 2025

Vistagen Therapeutics Appoints Paul R. Edick as Director - TradingView

Oct 29, 2025
pulisher
Oct 29, 2025

Vistagen Appoints Paul Edick to Its Board of Directors, Audit Committee and the Compensation Committee - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Vistagen Appoints Paul Edick to its Board of Directors - Business Wire

Oct 29, 2025
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):